Marie-Claude Catherine Hofmann
- UT MD Anderson Cancer Center · Surgery (NIH department code)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
- Program Leader
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 1938537Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2026 onlyCareer claims are limited to the years shown.
FY2026 award categories
- Surgery
NIH Funding · FY2026
Award data coverage
ScienceDex currently has one fiscal year of PI ranking data for this record. This does not establish the first NIH award or current employer.
Single fiscal year on record (FY2026): $2.7M in linked award amounts across 1 award record · Award-linked rank #6843.
FY2026 award records by amount
NIH award records listing Marie-Claude Catherine Hofmann as a PI. Multi-PI records show the full award amount for context.
- 1P01CA314921-01P01Contact PIImpACT: Improving Treatment Strategies for Anaplastic Thyroid Cancer Through Integration of Novel Therapies and Assessment of Tumor ResponseUT MD Anderson Cancer Center · Surgery (NIH department code)$2.7Maward amount
Award organization
Organizations that administered FY2026 awards listing Marie-Claude Catherine Hofmann as a PI.
FY2026 award administered by UT MD Anderson Cancer Center (TX).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2026First NIH AwardUT MD Anderson Cancer Center
- 2026$500K Cumulative Funding
- 2026$1M Cumulative Funding
- 2026$2M Cumulative Funding
- 2026Entered Top 50% NationallyRanked #6843
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Marie-Claude Catherine Hofmann.